Open AccessThe effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma
Author(s) -
Nazlı Gülsoy Kirnap,
Özlem Turhan İyidir,
Yusuf Bozkuş,
Şerife Mehlika Işildak,
Cüneyd Anıl,
Sevde Nur Fırat,
Canan Demir,
Aslı Nar,
Neslihan Başçıl Tütüncü
Publication year - 2020
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1902-176
Subject(s) - euthyroid , medicine , subclinical infection , anxiety , depression (economics) , thyroid , quality of life (healthcare) , thyroid carcinoma , beck anxiety inventory , endocrinology , gastroenterology , beck depression inventory , psychiatry , nursing , economics , macroeconomics
Overt thyroidism is known to cause neuropsychiatric disorders but studies on subclinical hyperthyroidism (SCH) are limited. Subclinical hyperthyroidism induction by administering L-Thyroxine (LT4) is the standard treatment method in differentiated thyroid carcinoma (DTC) follow-up. Our aim was to investigate whether anxiety, depression and quality of life are affected in DTC patients followed-up with exogenous SCH.